G. van Baaren

发表

Risk factors for preterm delivery: do they add to fetal fibronectin testing and cervical length measurement in the prediction of preterm delivery in symptomatic women?

Patrick M M Bossuyt, Guid Oei, Anneke Kwee, 2015, European journal of obstetrics, gynecology, and reproductive biology.

Cost-effectiveness of simulation-based team training in obstetric emergencies (TOSTI study).

B. Mol, S. Oei, G. van Baaren, 2017, European journal of obstetrics, gynecology, and reproductive biology.

Induction of labour versus expectant monitoring for gestational hypertension or mild pre-eclampsia between 34 and 37 weeks' gestation (HYPITAT-II): a multicentre, open-label randomised controlled trial

H. Bremer, J. Langenveld, C. D. Groot, 2011, BMC pregnancy and childbirth.

Cost‐effectiveness of diagnostic testing strategies including cervical‐length measurement and fibronectin testing in women with symptoms of preterm labor

P. Bossuyt, B. Mol, J. Post, 2018, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

The impact of fetal gender and ethnicity on the risk of spontaneous preterm delivery in women with symptoms of preterm labor

P. Bossuyt, B. Mol, J. V. D. van der Post, 2016, The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians.

The predictive value of quantitative fibronectin testing in combination with cervical length measurement in symptomatic women.

Y. Jacquemyn, B. Mol, M. Oudijk, 2016, American journal of obstetrics and gynecology.

Risk stratification with cervical length and fetal fibronectin in women with threatened preterm labor before 34 weeks and not delivering within 7 days

P. Bossuyt, B. Mol, J. V. D. van der Post, 2015, Acta obstetricia et gynecologica Scandinavica.

Which Factors Contribute to False-Positive, False-Negative, and Invalid Results in Fetal Fibronectin Testing in Women with Symptoms of Preterm Labor?

P. Bossuyt, B. Mol, J. V. D. van der Post, 2016, American Journal of Perinatology.

Comparison of the Actim Partus test and the fetal fibronectin test in the prediction of spontaneous preterm birth in symptomatic women undergoing cervical length measurement.

P. Bossuyt, B. Mol, J. V. D. van der Post, 2016, European journal of obstetrics, gynecology, and reproductive biology.

Prescribing patterns of antenatal corticosteroids in women with threatened preterm labor.

P. Bossuyt, B. Mol, J. V. D. van der Post, 2015, European journal of obstetrics, gynecology, and reproductive biology.

Randomized comparison of nifedipine and placebo in fibronectin-negative women with symptoms of preterm labor and a short cervix (APOSTEL-I Trial).

P. Bossuyt, B. Mol, J. V. D. van der Post, 2014, American journal of perinatology.

Economic analysis of use of pessary to prevent preterm birth in women with multiple pregnancy (ProTWIN trial)

G. Kleiverda, J. Langenveld, M. V. van Pampus, 2014, Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology.

Cost-effectiveness analysis of cardiovascular risk factor screening in women who experienced hypertensive pregnancy disorders at term.

B. Mol, A. Franx, C. D. de Groot, 2014, Pregnancy hypertension.

Cost-effectiveness analysis of cervical length measurement and fibronectin testing in women with threatened preterm labor.

P. Bossuyt, B. Mol, B. Opmeer, 2013, American journal of obstetrics and gynecology.

Predictive Value of Cervical Length Measurement and Fibronectin Testing in Threatened Preterm Labor

P. Bossuyt, B. Mol, J. V. D. van der Post, 2014, Obstetrics and gynecology.

Development and validation of a risk prediction model of preterm birth for women with preterm labour symptoms (the QUIDS study): A prospective cohort study and individual participant data meta-analysis

T. Lavender, R. Riley, R. Morris, 2021, PLoS medicine.

Preterm birth in singleton and multiple pregnancies: evaluation of costs and perinatal outcomes.

B. Mol, J. V. D. van der Post, E. Schuit, 2015, European journal of obstetrics, gynecology, and reproductive biology.

Correction: Induction of labour with a Foley catheter or oral misoprostol at term: the PROBAAT-II study, a multicentre randomised controlled trial

B. Mol, P. Pernet, M. Oudijk, 2013, BMC Pregnancy and Childbirth.

Relevance of individual participant data meta-analysis for studies in obstetrics: delivery versus expectant monitoring for hypertensive disorders of pregnancy.

B. Mol, J. Langenveld, S. Thangaratinam, 2015, European journal of obstetrics, gynecology, and reproductive biology.

Immediate delivery versus expectant monitoring for hypertensive disorders of pregnancy between 34 and 37 weeks of gestation (HYPITAT-II): an open-label, randomised controlled trial

B. Mol, H. Bremer, J. Langenveld, 2015, The Lancet.

H. Bremer, J. Langenveld, A. V. van Kaam, 2011, BMC pregnancy and childbirth.

Cost-effectiveness analysis of cardiovascular risk factor screening in women who experienced hypertensive pregnancy disorders at term.

B. Mol, A. Franx, C. D. de Groot, 2014, Pregnancy hypertension.

Predictive Value of Cervical Length Measurement and Fibronectin Testing in Threatened Preterm Labor

J. V. D. van der Post, H. Scheepers, G. Oei, 2014, Obstetrics and gynecology.

Risk factors for preterm delivery: do they add to fetal fibronectin testing and cervical length measurement in the prediction of preterm delivery in symptomatic women?

P. Bossuyt, B. Mol, H. Scheepers, 2015, European journal of obstetrics, gynecology, and reproductive biology.